Cocrystal Pharma (COCP) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

COCP Cocrystal Pharma

Watchlist

2.1500
+0.0900+4.37%

Close Nov 21 16:00 ET

2.1500
0.00000.00%

Post 20:01 ET

21.87MMarket Cap-1168P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Cocrystal Pharma Shares Are Trading Higher. The Stock May Be Moving on Continued Strength Following a Q3 Earnings Beat Reported on Wednesday
BenzingaNov 14 15:19 ET
Noble Financial Maintains Cocrystal Pharma(COCP.US) With Buy Rating, Maintains Target Price $10
Moomoo NewsNov 14 08:31 ET · Ratings
Cocrystal Pharma (COCP) Receives a Buy From Noble Financial
TipRanksNov 14 08:15 ET · Ratings
Cocrystal Pharma | 8-K: Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
SECNov 13 15:33 ET
Cocrystal Pharma | 10-Q: Q3 2024 Earnings Report
SECNov 13 08:32 ET · Announcements
Cocrystal Pharma Reports Q3 EPS (49c), Consensus (57c)
TipRanksNov 13 08:10 ET

Comments

Jaguar8

Jul 18 07:01

NEWS

$Cocrystal Pharma (COCP.US)$
Cocrystal Pharma Reports Favorable Results from Single-Ascending Dose Cohorts of Phase 1 Study with CDI-988, its Oral Pan-Viral Norovirus/Coronavirus Protease Inhibitor
Cocrystal Pharma (Nasdaq: COCP) reported favorable safety and tolerability results from the single-ascending dose (SAD) cohorts of its Phase 1 study for CDI-988, an oral pan-viral norovirus/coronavirus protease inhibitor.
The study, conducted in Australia, evaluated doses ranging from 100 mg to 60...

Jaguar8

May 1 11:47

$Cocrystal Pharma (COCP.US)$
NEWS
Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza